1. Home
  2. GRPN vs PRTA Comparison

GRPN vs PRTA Comparison

Compare GRPN & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Groupon Inc.

GRPN

Groupon Inc.

N/A

Current Price

$11.98

Market Cap

576.7M

ML Signal

N/A

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

N/A

Current Price

$9.79

Market Cap

482.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GRPN
PRTA
Founded
2008
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
576.7M
482.3M
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
GRPN
PRTA
Price
$11.98
$9.79
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$31.25
$19.00
AVG Volume (30 Days)
825.7K
383.0K
Earning Date
01-01-0001
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
14.69
N/A
EPS
N/A
N/A
Revenue
$2,843,877,000.00
$814,000.00
Revenue This Year
$4.17
$1,111.38
Revenue Next Year
$10.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.21
$4.32
52 Week High
$41.26
$14.60

Technical Indicators

Market Signals
Indicator
GRPN
PRTA
Relative Strength Index (RSI) 36.85 60.48
Support Level $11.86 $9.54
Resistance Level $13.80 $10.72
Average True Range (ATR) 0.71 0.55
MACD 0.09 0.11
Stochastic Oscillator 15.21 85.94

Price Performance

Historical Comparison
GRPN
PRTA

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: